eXmoor and Signadori Bio enter cell therapy partnership
Signadori is advancing a platform designed to overcome the challenges of treating solid cancers
Read More
Tag: Cell therapy
eXmoor pharma’s manufacturing facility receives licence from MHRA
The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services
Read More
Scientists develop micofluidic chip to make cell therapy safer
The chip removes cells, which could become tumours, before they are implanted in a patient
Read More
Positive results for Amphera’s MesoPher cell therapy
Treatment demonstrated significant survival data in addition to a sustained safety profile
Read More
Positive interim data for Ixaka’s lead ‘multi-cell’ therapy
The independent data monitoring committee (DMC) has recommended continuation of the Phase III trial
Read More
Cell and Gene Therapy Catapult forms consortium of over 20 organisations
Consortium will assess multiple process analytical technologies used in the cell and gene therapy industry
Read More
Cross-industry alliance launches to increase awareness of cell and gene therapies in the UK
The Cell & Gene Collective is aiming to advocate for the adoption of next-generation medicine in the UK
Read More
BMS to invest in new cell therapy manufacturing site in Europe
Construction on Leiden, Netherlands site anticipated to begin later this year
Read More
FDA green light for BMS, bluebird bio’s CAR-T therapy Abecma in multiple myeloma
CAR-T therapy cleared for use in adults with relapsed or refractory multiple myeloma
Read More
Rentschler Biopharma to build cell and gene therapy manufacturing capabilities in the UK
German CDMO will build new manufacturing capabilities at CGT Catapult site
Read More
Bayer establishes new cell and gene therapy platform
Platform will enable Bayer to pursue external collaborations and bolster internal capabilities
Read More
Bayer to acquire cell and gene therapy specialist AskBio
Deal could be worth up to $4bn dependent on success milestones
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
